E-ISSN 2231-3206 | ISSN 2320-4672
 
2023, Vol: 13, Issue: 3
13/3Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research 


A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital

Anupama M, Sharath Kumar JV, Shetty GG.

Abstract
Background: ST-segment elevation myocardial infarction (STEMI) is the most dramatic manifestation of coronary artery disease, acute STEMI is a clinical syndrome defined by characteristic symptoms of myocardial ischemia in association with persistent electrocardiographic ST elevation and subsequent release of biomarkers of myocardial necrosis. Reperfusion with thrombolysis or PCI (percutaneous coronary intervention) is the current standard of care for STEMI.

Aims and Objectives: The aim of the study was to compare the effectiveness of fibrinolytic therapy and primary PCI which are the available reperfusion strategies for STEMI.

Materials and Methods: This prospective and observational study was conducted at a tertiary care hospital in Bangalore. Patients presenting with STEMI to emergency department were treated with either fibrinolysis or PCI as per protocol. Patients in each arm were followed up to know the differences in outcome at discharge and 30-day follow-up.

Results: Patients admitted with STEMI had overall in hospital mortality of 17 (7.1%) patients, of which 9 (7.6%) patients were from fibrinolysis group and 8 (6.6%) patients from PCI group with no statistically significant difference (P = 0.760). There was significant incidence (P = 0.001) of reinfarct in fibrinolysis group (9.3%) when compared to PCI group (0%).

Conclusion: There was no statistically significant mortality difference at discharge and at 30 day between fibrinolysis and primary PCI in patients with STEMI in our study, this may be attributed to use of rescue PCI in failed fibrinolysis patients and early tricuspid valve repair in many patients after fibrinolysis.

Key words: Fibrinolysis; Primary PCI; ST-Segment Elevation; Myocardial Infarction


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Anupama M
Articles by Sharath Kumar JV
Articles by Shetty GG
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

M A, JV SK, GG S. A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(11): 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022

Web Style

M A, JV SK, GG S. A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. https://www.njppp.com/?mno=118248 [Access: March 02, 2023]. doi:10.5455/njppp.2023.13.09472202202102022

AMA (American Medical Association) Style

M A, JV SK, GG S. A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(11): 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


Vancouver/ICMJE Style

M A, JV SK, GG S. A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2022), [cited March 02, 2023]; 12(11): 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


Harvard Style

M, A., JV, . S. K. & GG, . S. (2022) A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 12 (11), 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


Turabian Style

M, Anupama, Sharath Kumar JV, and Shetty GG. 2022. A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (11), 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


Chicago Style

M, Anupama, Sharath Kumar JV, and Shetty GG. "A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


MLA (The Modern Language Association) Style

M, Anupama, Sharath Kumar JV, and Shetty GG. "A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 12.11 (2022), 1848-1853. Print. doi:10.5455/njppp.2023.13.09472202202102022


APA (American Psychological Association) Style

M, A., JV, . S. K. & GG, . S. (2022) A study to compare fibrinolytic therapy versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (11), 1848-1853. doi:10.5455/njppp.2023.13.09472202202102022


Author LoginReviewer LoginAbout PublisherEditorial PoliciesPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information
Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology.
For best results, please use Internet Explorer or Google Chrome

Contact Information


Publisher

publishernjppp@gmail.com

 

Editorial query

editornjppp1@gmail.com

MOB - 8780040272